Figure 1.

A 30-year-old female patient who presented with concerns related to skin quality (pore size and skin texture) and a desire to narrow her lower face and address excess submental volume. The patient was injected intradermally with 100 U of incobotulinum toxin in 5 mL saline over her entire face. The patient is shown at baseline (A, E); and at postinjection week 1 (B, F); week 4 (C, G); and week 12 (D, H). Closed circles in the midface (Black) indicate 0.5 U, lighter closed circles on the lateral face and DAO (yellow) indicate 1 U, and darker closed circles on the lower lateral face (green) dots indicate 2 U, for a total of 82 U.